RXO (NYSE:RXO) Price Target Raised to $20.00

RXO (NYSE:RXO) had its price objective increased by Susquehanna from $18.00 to $20.00 in a research note published on Tuesday, MarketBeat reports. Susquehanna currently has a negative rating on the stock.

Other analysts have also issued reports about the company. Wall Street Zen raised RXO from a “sell” rating to a “hold” rating in a research note on Saturday, May 9th. Morgan Stanley reissued an “equal weight” rating and set a $22.00 target price (up from $19.00) on shares of RXO in a research note on Thursday, May 7th. Citigroup increased their target price on shares of RXO from $24.00 to $30.00 and gave the stock a “neutral” rating in a report on Thursday, July 9th. Barclays raised their price target on shares of RXO from $20.00 to $28.00 and gave the company an “overweight” rating in a research note on Thursday, June 25th. Finally, Stifel Nicolaus lifted their price target on shares of RXO from $22.00 to $30.00 and gave the company a “buy” rating in a report on Monday. Four equities research analysts have rated the stock with a Buy rating, twelve have assigned a Hold rating and three have assigned a Sell rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Hold” and an average target price of $23.57.

RXO Stock Up 5.4%

NYSE RXO opened at $28.52 on Tuesday. The business has a fifty day moving average price of $25.54 and a two-hundred day moving average price of $18.99. The company has a debt-to-equity ratio of 0.28, a current ratio of 1.27 and a quick ratio of 1.27. RXO has a fifty-two week low of $10.43 and a fifty-two week high of $29.86. The stock has a market capitalization of $4.70 billion, a PE ratio of -46.76 and a beta of 2.03.

RXO (NYSE:RXO) last issued its earnings results on Thursday, May 7th. The company reported ($0.09) earnings per share for the quarter, meeting analysts’ consensus estimates of ($0.09). RXO had a negative return on equity of 1.16% and a negative net margin of 1.83%.The firm had revenue of $1.43 billion for the quarter, compared to the consensus estimate of $1.34 billion. During the same quarter last year, the business posted ($0.03) EPS. The company’s revenue was down .6% compared to the same quarter last year. Equities analysts expect that RXO will post 0.07 earnings per share for the current fiscal year.

Hedge Funds Weigh In On RXO

Several large investors have recently bought and sold shares of the company. City Holding Co. boosted its stake in shares of RXO by 227.6% during the second quarter. City Holding Co. now owns 1,245 shares of the company’s stock valued at $34,000 after purchasing an additional 865 shares in the last quarter. Geneos Wealth Management Inc. acquired a new position in shares of RXO in the first quarter valued at approximately $30,000. Cassaday & Co Wealth Management LLC acquired a new position in shares of RXO in the first quarter valued at approximately $29,000. Flagship Harbor Advisors LLC acquired a new position in shares of RXO in the fourth quarter valued at approximately $25,000. Finally, Quarry LP bought a new position in RXO in the 3rd quarter valued at approximately $33,000. 92.73% of the stock is currently owned by institutional investors.

Key RXO News

Here are the key news stories impacting RXO this week:

• Positive Sentiment: Truist Financial raised its price target on RXO from $26 to $30 and reiterated a buy rating, signaling confidence in further upside from current levels. Analyst update via Benzinga
• Positive Sentiment: BMO Capital Markets initiated coverage with an outperform rating and a $35 price target, one of the more bullish calls in the latest batch. BMO Capital Markets initiation via Benzinga
• Neutral Sentiment: Goldman Sachs raised its target from $18 to $20 but kept a neutral rating, suggesting valuation may be more limited despite the higher target. Goldman Sachs update via Benzinga
• Neutral Sentiment: Citizens JMP initiated coverage with a market perform rating, indicating a more cautious stance and no strong conviction either way. Citizens JMP coverage via Zacks
• Neutral Sentiment: Susquehanna also lifted its price target to $20, but that still sits well below the current trading level, implying limited near-term upside from their perspective. Susquehanna update

About RXO

RXO Inc (NYSE: RXO) is a leading asset-light provider of digital freight brokerage and managed transportation solutions. The company leverages a proprietary technology platform to connect shippers with a network of third-party carriers, enabling optimized route planning, real-time shipment tracking, and dynamic pricing. RXO’s end-to-end service model spans full truckload, less-than-truckload (LTL), intermodal and cross-border freight movements, designed to improve efficiency and reduce transportation costs for its customers.

Operating primarily across North America, RXO serves a diverse base of shippers in industries ranging from retail and consumer goods to manufacturing and automotive.